Stock Screener App

Frei -

Installieren

Drug Manufacturers - Specialty & Generic

469.49

0.38% 1.79

United Therapeutics Corp (UTHR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt UTHR? Forum Prognose Aktiensplit

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

A Look Back at Therapeutics Stocks' Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack - Finviz

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) - Finviz

Mutual of America Capital Management LLC Acquires 4,036 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Mitsubishi UFJ Trust & Banking Corp Sells 13,401 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Strs Ohio Has $4.22 Million Stake in United Therapeutics Corporation $UTHR - MarketBeat

What's Going On With United Therapeutics Stock Monday?United Therapeutics (NASDAQ:UTHR) - Benzinga

United Therapeutics reports positive phase 1 results for bioengineered liver By Investing.com - Investing.com Canada

How Investors May Respond To United Therapeutics (UTHR) Positive Early Data For Bioengineered Liver Support Device - Yahoo Finance

United Therapeutics reports positive phase 1 results for bioengineered liver - Investing.com

Retirement Systems of Alabama Sells 18,709 Shares of United Therapeutics Corporation $UTHR - MarketBeat

World’s first FDA-cleared bioengineered liver trial meets survival goal - Stock Titan

United Therapeutics Corporation (UTHR) Stock Analysis: Potential Upside and Robust Growth in the Biotech Sphere - DirectorsTalk Interviews

United Therapeutics appoints biomedical research leader to board By Investing.com - Investing.com Nigeria

United Therapeutics Appoints Kevin J. Tracey To Board - citybiz

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Board of Directors, Effective January 21, 2026 - marketscreener.com

United Therapeutics appoints biomedical research leader to board - Investing.com

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - United Therapeutics Investor Relations

Element Squared LLC Buys 5,027 Shares of United Therapeutics Corp (UTHR) - GuruFocus

Marquette Asset Management, LLC Buys 1 Shares of United Therapeutics Corp (UTHR) - GuruFocus

United Therapeutics Corporation (UTHR): A Bull Case Theory - Finviz

Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat

Polaris Capital Management LLC Sells 5,600 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Reassessing United Therapeutics (UTHR) Valuation After Strong 1 Year Share Price Performance - Yahoo Finance

United Therapeutics COO sells $10.7 million in UTHR stock - Investing.com

United Therapeutics’ Phase 3 Ralinepag Trial Reaches Completion, Setting Up a Key Catalyst in Pulmonary Arterial Hypertension - TipRanks

United Therapeutics Corporation $UTHR Shares Sold by State of Alaska Department of Revenue - MarketBeat

SG Americas Securities LLC Purchases 7,483 Shares of United Therapeutics Corporation $UTHR - MarketBeat

United Therapeutics Corporation $UTHR Position Decreased by Nepsis Inc. - MarketBeat

How United Therapeutics Corporation (UTH) stock expands through international marketsTreasury Yields & Verified Swing Trading Watchlists - Улправда

Is United Therapeutics Corporation stock a good choice for value investorsJuly 2025 Recap & AI Enhanced Execution Alerts - Улправда

MannKind Provides Business Updates and 2026 Growth Drivers - Benzinga

Robeco Institutional Asset Management B.V. Has $38.19 Million Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat

United Therapeutics (NASDAQ:UTHR) COO Sells $7,127,932.50 in Stock - MarketBeat

Director Jan Malcolm Sells Shares of United Therapeutics Corp - GuruFocus

United Therapeutics (UTHR): UBS Raises Price Target, Maintains B - GuruFocus

Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Performance Tethered To Its Attractive Financial Prospects? - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat

United Therapeutics Corporation (UTHR) Stock Analysis: A Healthcare Giant with Strong Growth Potential and Robust Analyst Support - DirectorsTalk Interviews

Biotech developing organ transplant tech steps onto J.P. Morgan stage - Stock Titan

United Therapeutics Corporation $UTHR Shares Bought by Merit Financial Group LLC - MarketBeat

Allspring Global Investments Holdings LLC Acquires 4,944 Shares of United Therapeutics Corporation $UTHR - MarketBeat

United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares - MarketBeat

United Therapeutics Corporation $UTHR Position Increased by Cwm LLC - MarketBeat

VIRGINIA RETIREMENT SYSTEMS ET Al Sells 137,900 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 22,500 Shares - MarketBeat

United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView — Track All Markets

United Therapeutics president sells $3.5m in stock - MSN

United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing - marketscreener.com

Death Cross: Can United Therapeutics Corporation stock sustain market leadershipTrend Reversal & AI Based Buy/Sell Signal Reports - moha.gov.vn

Pacer Advisors Inc. Decreases Position in United Therapeutics Corporation $UTHR - MarketBeat

S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag - 富途牛牛

S&P 500 Futures Flat in Premarket Trading; United Therapeutics, Intel Lag - Barron's

United Therapeutics (NASDAQ:UTHR) Reaches New 1-Year HighHere's What Happened - MarketBeat

Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus

Jan Malcolm Sells 50 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

United Therapeutics (NASDAQ:UTHR) Director Louis Sullivan Sells 5,950 Shares - MarketBeat

United Therapeutics Director Malcolm Jan Sells Shares - TradingView — Track All Markets

VTRS

$13.09

0.15%

NBIX

$136.06

1.38%

RGC

$24.99

10.41%

ELAN

$24.08

0.50%

RDY

$13.42

1.13%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters